Information  X 
Enter a valid email address

Benchmark Hlgs PLC (BMK)

  Print   

Monday 11 November, 2019

Benchmark Hlgs PLC

Chief Financial Officer Appointment Update

RNS Number : 8782S
Benchmark Holdings PLC
11 November 2019
 

11 November 2019

 

 

Benchmark Holdings plc

 

("Benchmark" or the "Company")

 

Chief Financial Officer Appointment Update

Benchmark, the aquaculture health, nutrition and genetics business, is pleased to provide an update following the Company's 14 August 2019 announcement of the appointment of Septima Maguire as Chief Financial Officer.

Septima has joined the business today, but will be appointed CFO with effect from 18 December 2019. Mark Plampin remains CFO of the Group until that date to ensure an effective transition.

Septima joins Benchmark from Dechra Pharmaceuticals PLC, the FTSE 250 international provider of specialist veterinary pharmaceuticals and related products, where she spent four years. Having joined as Group Financial Controller she was Acting Group Finance Director between 2016 and 2017. She was most recently Corporate Development Director overseeing all aspects of acquisition activities, strategic projects, business development and investment initiatives playing a significant role in supporting the company during a period of high growth.

Previously, Septima held a number of senior finance roles at Ardagh Group S.A., the international packaging manufacturer with revenues of €9.1bn, over a period of six years.

 

Enquiries

 

For further information, please contact:

 

Benchmark Holdings plc

Tel:  020 3915 1236

Peter George, CEO

 

Ivonne Cantu, Investor Relations

 

 

 

Numis (Broker and NOMAD) 

Tel: 020 7260 1000

James Black / Freddie Barnfield / Duncan Monteith

 

 

 

 

 

 

 

MHP Communications

Tel:  020 3128 8742

Katie Hunt / Reg Hoare / Alistair de Kare-Silver                                          [email protected]

 

 

About Benchmark 
Benchmark's mission is to enable food producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (artemia), sea lice treatments, training and data management tools. Find out more at www.benchmarkplc.com

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BOABPBLTMBAMBAL

a d v e r t i s e m e n t